Vident Advisory’s Labcorp LH Stock Holding History

Vident Advisory’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.76M	Buy	29,097 +7,136	+32%	+$1.93M	0.07%	251
2025 Q4	$5.51M	Buy	21,961 +4,232	+24%	+$1.12M	0.05%	304
2025 Q3	$5.09M	Buy	17,729 +5,081	+40%	+$1.36M	0.05%	305
2025 Q2	$3.32M	Buy	12,648 +10,427	+469%	+$2.54M	0.04%	369
2025 Q1	$517K	Buy	2,221 +744	+50%	+$181K	0.01%	1015
2024 Q4	$339K	Sell	1,477 -4	-0.3%	-$918	0.01%	1126
2024 Q3	$331K	Sell	1,481 -15,859	-91%	-$3.49M	0.01%	1100
2024 Q2	$3.53M	Buy	17,340 +16,179	+1,394%	+$3.29M	0.1%	214
2024 Q1	$254K	Buy	1,161 +59	+5%	+$13K	0.01%	1108
2023 Q4	$250K	Sell	1,102 -47,426	-98%	-$9.96M	0.01%	1099
2023 Q3	$9.76M	Buy	+48,528	New	+$10.2M	0.3%	99

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vident Advisory's LH Position: Q1 2026 in Review

Vident Advisory increased its Labcorp (LH) stake by 32% in Q1 2026, buying an estimated $1.93M and bringing the position to 29,097 shares worth $7.76M. The position accounts for 0.07% of the portfolio, ranked #251.

Vident Advisory first reported a position in LH in Q3 2023 and has held it in 11 quarters since. The position peaked at $9.76M in Q3 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Vident Advisory held 29,097 shares of Labcorp worth $7.76M as of Q1 2026.
Vident Advisory bought 7,136 Labcorp shares in Q1 2026, an estimated $1.93M.
Labcorp made up 0.07% of Vident Advisory's portfolio in Q1 2026, its #251 holding.
Vident Advisory first reported a position in Labcorp in Q3 2023 and has held it in 11 quarters since.
Vident Advisory's Labcorp position peaked at $9.76M in Q3 2023.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.